Combined alpha- and beta-adrenergic blockade in the treatment of hypertension: myth or reality? Workshop held in Corsendonck (Belgium) on February 28, 1981.
出版信息
J Cardiovasc Pharmacol. 1981;3 Suppl 1:S1-74.
PMID:6169955
Abstract
摘要
相似文献
1
2
Labetalol, an alpha- and beta-adrenergic blocking drug in the treatment of hypertension.拉贝洛尔，一种用于治疗高血压的α和β肾上腺素能阻滞剂。
Am Heart J. 1977 Jan;93(1):124-5. doi: 10.1016/s0002-8703(77)80182-8.
3
Labetalol therapy in patients with systemic hypertension and angina pectoris: effects of combined alpha and beta adrenoceptor blockade.拉贝洛尔治疗系统性高血压和心绞痛患者：α和β肾上腺素能受体联合阻滞的效果
Am J Cardiol. 1981 Nov;48(5):917-28. doi: 10.1016/0002-9149(81)90359-3.
4
[Combined alpha and beta adrenergic receptor blockade in the treatment of renal hypertension].α和β肾上腺素能受体联合阻断治疗肾性高血压
Wien Med Wochenschr Suppl. 1981;69:14-6.
5
Combined alpha- and beta-receptor inhibition in the treatment of hypertension.联合α和β受体抑制治疗高血压。
Drugs. 1984;28 Suppl 2:51-68. doi: 10.2165/00003495-198400282-00005.
6
[Hypertensive emergencies: clinical evaluation of the use of a new drug: labetalol hydrochloride].[高血压急症：一种新药——盐酸拉贝洛尔临床应用评估]
Minerva Cardioangiol. 1980 May;28(5):309-14.
7
Labetalol, a new alpha- and beta-adrenoreceptor blocking agent, in hypertension.
Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):763-4.
8
Labetolol--combined alpha and beta blockade for hypertension.
Scott Med J. 1978 Oct;23(4):279-80. doi: 10.1177/003693307802300405.
9
Labetalol (AH5158), a competitive alpha- and beta-receptor blocking drug, in the management of hypertension.拉贝洛尔（AH5158），一种竞争性α和β受体阻断药物，用于治疗高血压。
Aust N Z J Med. 1976 Aug;6(3 Suppl):83-8. doi: 10.1111/j.1445-5994.1976.tb03341.x.
10
Labetalol in hypertensive patients with angina pectoris: beneficial effect of combined alpha- and beta-adrenoreceptor blockade.
Clin Sci Mol Med Suppl. 1978 Dec;4:283s-286s. doi: 10.1042/cs055283s.
Zotero 插件